Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Chong Kun Dang Pharmaceutical
* In patients with essential hypertension inadequately controlled by S-Amlodipine monotherapy to evaluate the efficacy and safety of two dose combination of S-Amlodipine/Telmisartan (2.5/40mg amd 2.5/80mg) compared with S-Amlodipine monotherapy (2.5mg)during 8weeks. * Included S-Amlodipine run-in period(during 4 weeks\_single blind) and Treatment period(during 8 weeks\_double blind).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted